Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
Though antiretroviral therapy is the standard of care for people living with HIV, its treatment limitations, burdens, stigma and costs lead to continued interest in HIV cure research. Early-phase cure trials, particularly those that include analytic treatment interruption (ATI), involve uncertain an...
Authors: | ; ; ; ; ; ; ; ; ; ; ; ; |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
BMJ Publ.
2018
|
In: |
Journal of medical ethics
Year: 2018, Volume: 44, Issue: 4, Pages: 270-276 |
Online Access: |
Volltext (JSTOR) Volltext (kostenfrei) Volltext (kostenfrei) |